Healthcare Services

One of the Major Drivers of the Nanotechnology In Cancer Treatment Market Is the Rising Demand For Targeted Therapies Drives Growth In Nanotechnology-Based Cancer Treatment Due To Their Precision In Attacking Cancer Cells

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Nanotechnology In Cancer Treatment Market During 2026–2030?

The nanotechnology in cancer treatment market has shown rapid expansion in recent years. Its value is set to rise from $159.07 billion in 2025 to $183.23 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.2%. This historical growth can be linked to several factors, including increasing cancer incidence rates, advancements in nanomaterial engineering, an expansion of oncology research funding, growing collaboration between pharmaceutical companies and research institutions, and the early clinical success of nano-based therapies.

The nanotechnology in cancer treatment market is anticipated to experience significant expansion over the coming years. Its value is projected to reach $319.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.9%. This expansion during the forecast period stems from factors such as the growing embrace of personalized cancer treatment methods, increased funding for nanomedicine research, an increase in clinical trials utilizing nanotechnology, a heightened emphasis on less invasive cancer therapies, and progress in nano-enabled diagnostic tools. Key trends anticipated during this period involve the increasing creation of drug delivery systems based on nanoparticles, a rise in the adoption of targeted cancer treatments, expanding application of multifunctional nanomaterials, the broadening scope of personalized oncology solutions, and a stronger emphasis on mitigating the adverse effects of chemotherapy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27357&type=smp

What Drivers Are Expected To Influence The Nanotechnology In Cancer Treatment Market During The Forecast Period?

The increasing requirement for targeted therapies is anticipated to stimulate the expansion of nanotechnology within the cancer treatment market moving forward. These therapies represent cancer treatments designed to precisely address specific molecular markers or pathways implicated in the development and advancement of tumors. The heightened demand for targeted therapies stems from their capacity to accurately target cancerous cells, thereby lessening harm to healthy tissue and diminishing adverse effects. Nanotechnology applied to cancer treatment bolsters targeted therapies by facilitating the exact delivery of medications straight to cancer cells, thereby boosting efficacy and reducing damage to healthy tissues. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of Q1 2023, there were 247 gene therapies in Phase II, a figure which subsequently increased by 5% to 260 by the end of Q2 2023. Consequently, the increasing requirement for targeted therapies is fueling the expansion of nanotechnology in the cancer treatment market.

How Are The Various Segments Of The Nanotechnology In Cancer Treatment Market Categorized?

The nanotechnology in cancer treatment market covered in this report is segmented –

1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles

2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance

3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types

4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems

5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)

Subsegments:

1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes

2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers

3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles

What Key Developments And Trends Are Impacting The Nanotechnology In Cancer Treatment Market?

Leading companies operating in the nanotechnology in cancer treatment market are concentrating on developing advanced therapies, such as immunotherapy nano formulation, to improve immune system targeting and minimize adverse effects in cancer patients. Immunotherapy nano formulation utilizes nanotechnology for the direct delivery of immune-based treatments to target sites, enhancing precision while also improving drug stability, bioavailability, and the activation of immune responses. For instance, in December 2023, Cello Therapeutics, a US-based biotechnology company, introduced CE120, a broad-spectrum therapeutic cancer nano vaccine that achieved Food and Drug Administration clearance. This treatment signifies the initial clinical application of platelet membrane-coated nanoparticles for addressing solid tumors. CE120 integrates targeted drug delivery with immune system activation, aiming to eliminate tumors and prevent their recurrence. Its distinctive nanotechnology platform boosts both therapeutic precision and immune response. This accomplishment positions CE120 as a pioneering nanomedicine in cancer treatment.

Which Major Firms Influence Developments In The Nanotechnology In Cancer Treatment Market?

Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., Selecta Biosciences Inc., Bind Therapeutics Inc., BlueWillow Biologics Inc., Nanobiomed Inc.

Read the full nanotechnology in cancer treatment market report here:

https://www.thebusinessresearchcompany.com/report/nanotechnology-in-cancer-treatment-global-market-report

Which Region Is Forecast To Lead The Nanotechnology In Cancer Treatment Market In Terms Of Market Size?

North America was the largest region in the nanotechnology in cancer treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nanotechnology In Cancer Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27357&type=smp

Browse Through More Reports Similar to the Global Nanotechnology In Cancer Treatment Market 2026, By The Business Research Company

Metal Nanoparticles Global Market Report

https://www.thebusinessresearchcompany.com/report/metal-nanoparticles-global-market-report

Nanomaterials Global Market Report

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Nanoparticle Analysis Global Market Report

https://www.thebusinessresearchcompany.com/report/nanoparticle-analysis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795